This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jim Cramer's Mad Dash: ISRG STZ

NEW YORK (TheStreet) -- TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, called Intuitive Surgical's (ISRG - Get Report) recent earnings results a "severe disappointment" during CNBC's "Cramer's Mad Dash" segment Wednesday.

However, analysts continue to stand behind the name, Cramer said. He suggested investors listen to TheStreet's Herb Greenberg's view on the stock, which have been relatively accurate. 

Cramer added that product demand seems to be the main problem for Intuitive Surgical, evident by the 24% year-over-year decline in sales. "Stay away from ISRG," he told investors because perhaps "demand has peaked" for its medical devices. 

Turning to Constellation Brands (STZ - Get Report), Cramer was much more bullish. The company beat on bottom-line estimates and provided strong fiscal year guidance. 

Must Read: Pop Goes the Internet World

He said the company's 2013 acquisition of Grupo Modelo -- which includes Crown Imports LLC, the maker of Corona -- has been a real difference-maker for the company. 

Because of the deal, Cramer said shares of STZ are still cheap, despite the stock appreciating 69% in the past 12 months thanks to earnings results and guidance that continue to grow.

-- Written by Bret Kenwell in Petoskey, Mich.

At the time of publication, Cramer's Action Alerts PLUS had no position in companies mentioned.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ISRG $617.89 0.42%
STZ $159.38 0.37%
AAPL $92.53 -0.76%
FB $119.22 1.20%
GOOG $711.32 1.40%


Chart of I:DJI
DOW 17,718.62 +57.91 0.33%
S&P 500 2,056.05 +5.42 0.26%
NASDAQ 4,729.6070 +12.5130 0.27%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs